Comparison of the hypolipidemic effect of gemfibrozil versus simvastatin in patients with type III hyperlipoproteinemia
- 1 July 1999
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 138 (1) , 156-162
- https://doi.org/10.1016/s0002-8703(99)70262-0
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Apolipoprotein E polymorphism in health and diseasePublished by Elsevier ,2004
- Apo E variants in patients with type III hyperlipoproteinemiaAtherosclerosis, 1996
- Plasma Concentration of Apolipoprotein E in Intermediate-Sized Remnant-Like Lipoproteins in Normolipidemic and Hyperlipidemic SubjectsArteriosclerosis, Thrombosis, and Vascular Biology, 1996
- Apolipoprotein E-1Harrisburg: a new variant of apolipoprotein E dominantly associated with type III hyperlipoproteinemiaBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1989
- Type III hyperlipoproteinemia associated with apolipoprotein E phenotype E3/3. Structure and genetics of an apolipoprotein E3 variant.Journal of Clinical Investigation, 1989
- Hypolipidemic effects of HMG-CoA reductase inhibitors in patients with hypercholesterolemiaThe American Journal of Cardiology, 1987
- Apolipoprotein E2-Christchurch (136 Arg----Ser). New variant of human apolipoprotein E in a patient with type III hyperlipoproteinemia.Journal of Clinical Investigation, 1987
- Lipid-Lowering DrugsDrugs, 1987
- A novel electrophoretic variant of human apolipoprotein E. Identification and characterization of apolipoprotein E1.Journal of Clinical Investigation, 1984
- Identification of a new structural variant of human apolipoprotein E, E2(Lys146 leads to Gln), in a type III hyperlipoproteinemic subject with the E3/2 phenotype.Journal of Clinical Investigation, 1983